Omalizumab normalizes the gene expression signature of lesional skin in patients with chronic spontaneous urticaria: a randomized, double‐blind, placebo‐controlled study

Allergy, Volume 0, Issue ja, -Not available-.


https://ift.tt/2MS0Onn